BSE Live
Jan 20, 14:41Prev. Close
845.20
Open Price
846.10
Bid Price (Qty.)
831.20 (11)
Offer Price (Qty.)
832.00 (5)
NSE Live
Jan 20, 14:41Prev. Close
845.75
Open Price
851.20
Bid Price (Qty.)
831.15 (3)
Offer Price (Qty.)
831.60 (29)
| Key Financial Ratios of Natco Pharma (in Rs. Cr.) | Mar 10 | Mar 09 | Mar 08 | Mar 07 | Mar 06 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 16.93 | 15.24 | 14.28 | 11.02 | 8.76 | |
| Diluted EPS (Rs.) | 16.93 | 15.24 | 14.28 | 11.02 | 8.76 | |
| Cash EPS (Rs.) | 21.35 | 18.93 | 17.35 | 14.69 | 12.53 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 107.09 | 91.97 | 78.17 | 65.16 | 54.35 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 107.09 | 91.97 | 78.17 | 65.16 | 54.35 | |
| Dividend / Share(Rs.) | 2.00 | 1.25 | 1.25 | 1.20 | 1.25 | |
| Revenue from Operations/Share (Rs.) | 109.92 | 96.94 | 82.34 | 67.24 | 59.79 | |
| PBDIT/Share (Rs.) | 31.23 | 27.98 | 24.49 | 19.07 | 14.75 | |
| PBIT/Share (Rs.) | 26.80 | 24.29 | 21.42 | 16.32 | 12.31 | |
| PBT/Share (Rs.) | 22.17 | 19.39 | 18.39 | 14.26 | 9.74 | |
| Net Profit/Share (Rs.) | 16.93 | 15.24 | 14.28 | 11.02 | 8.76 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 28.40 | 28.86 | 29.73 | 28.36 | 24.66 | |
| PBIT Margin (%) | 24.38 | 25.05 | 26.01 | 24.26 | 20.58 | |
| PBT Margin (%) | 20.17 | 20.00 | 22.33 | 21.20 | 16.29 | |
| Net Profit Margin (%) | 15.40 | 15.72 | 17.34 | 16.38 | 14.64 | |
| Return on Networth / Equity (%) | 15.81 | 16.57 | 18.27 | 16.91 | 16.11 | |
| Return on Capital Employed (%) | 12.13 | 12.30 | 14.07 | 13.25 | 11.70 | |
| Return on Assets (%) | 8.94 | 8.63 | 9.89 | 8.96 | 7.98 | |
| Total Debt/Equity (X) | 0.40 | 0.49 | 0.43 | 0.42 | 0.54 | |
| Asset Turnover Ratio (%) | 58.07 | 54.94 | 57.06 | 54.72 | 54.53 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 1.29 | 1.53 | 1.50 | 1.49 | 1.50 | |
| Quick Ratio (X) | 0.82 | 1.09 | 1.04 | 1.04 | 1.05 | |
| Inventory Turnover Ratio (X) | 4.71 | 4.20 | 4.17 | 3.77 | 3.84 | |
| Dividend Payout Ratio (NP) (%) | 11.81 | 8.20 | 8.57 | 11.15 | 14.16 | |
| Dividend Payout Ratio (CP) (%) | 9.36 | 6.60 | 7.05 | 8.36 | 9.90 | |
| Earnings Retention Ratio (%) | 88.19 | 91.80 | 91.43 | 88.85 | 85.84 | |
| Cash Earnings Retention Ratio (%) | 90.64 | 93.40 | 92.95 | 91.64 | 90.10 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 493.26 | 241.54 | 311.85 | 454.58 | 415.42 | |
| EV/Net Operating Revenue (X) | 1.59 | 0.89 | 1.35 | 2.45 | 2.56 | |
| EV/EBITDA (X) | 5.61 | 3.08 | 4.54 | 8.62 | 10.37 | |
| MarketCap/Net Operating Revenue (X) | 1.22 | 0.50 | 1.03 | 2.16 | 2.23 | |
| Retention Ratios (%) | 88.18 | 91.79 | 91.42 | 88.84 | 85.83 | |
| Price/BV (X) | 1.25 | 0.52 | 1.08 | 2.23 | 2.46 | |
| Price/Net Operating Revenue | 1.22 | 0.50 | 1.03 | 2.16 | 2.23 | |
| Earnings Yield | 0.13 | 0.32 | 0.17 | 0.08 | 0.07 |
26.11.2025
Natco Pharma Consolidated September 2025 Net Sales at Rs 1,363.00 crore, down 0.59% Y-o-Y
24.11.2025
Natco Pharma Standalone September 2025 Net Sales at Rs 1,264.30 crore, down 2.19% Y-o-Y
24.11.2025
24.11.2025
26.11.2025
Natco Pharma Consolidated September 2025 Net Sales at Rs 1,363.00 crore, down 0.59% Y-o-Y
24.11.2025
Natco Pharma Standalone September 2025 Net Sales at Rs 1,264.30 crore, down 2.19% Y-o-Y
14.11.2025
Natco Pharma Consolidated September 2025 Net Sales at Rs 1,363.00 crore, down 0.59% Y-o-Y
09.09.2025
Natco Pharma Standalone June 2025 Net Sales at Rs 1,192.70 crore, down 3.57% Y-o-Y